[1] LISMAN T,CALDWELL SH,BURROUGHS AK,et al. Hemostasis and thrombosis in patients with liver disease:The ups and downs[J]. J Hepatol,2010,53(2):362-371.
|
[2] LISMAN T,STRAVITZ RT. Rebalanced hemostasis in patients with acute liver failure[J]. Semin Thromb Hemost,2015,41(5):468-473.
|
[3] WANG YL,CHEN H,LIU Y,et al. Effect of thromboelastography on coagulation states evaluation in patients with decompensated cirrhosis[J]. J Southeast Univ(Med Sci Edi),2016,35(2):215-219.(in Chinese)王玉连,陈洪,刘洋,等.血栓弹力图在评估肝硬化患者凝血状态中的作用[J].东南大学学报(医学版),2016,35(2):215-219.
|
[4] INTAGLIATA NM,DAVIS J,CALDWELL SH. Coagulation pathways,hemostasis,and thrombosis in liver failure[J]. Semin Respir Crit Care Med,2018,39(5):598-608.
|
[5] LISMAN T,PORTE RJ. Pathogenesis,prevention,and management of bleeding and thrombosis in patients with liver diseases[J]. Res Pract Thromb Haemost,2017,1(2):150-161.
|
[6] SARIN SK,CHOUDHURY A,SHARMA MK,et al. Acute-on-chronic liver failure:Consensus recommendations of the Asian Pacific association for the study of the liver(APASL):An update[J]. Hepatol Int,2019,13(4):353-390.
|
[7] BLASI A,CALVO A,PRADO V,et al. Coagulation failure in patients with acute-on-chronic liver failure and decompensated cirrhosis:Beyond the international normalized ratio[J].Hepatology,2018,68(6):2325-2337.
|
[8] ZHAO JM,ZHANG L,ZHAO PL,et al. Relationship between main clinical indexes and prognosis of patients with liver failure[J/CD]. Chin J Liver Dis(Electronic Version),2019,11(1):68-71.(in Chinese)赵俊梅,张璐,赵培利,等.肝功能衰竭患者主要临床指标与预后的关系[J/CD].中国肝脏病杂志(电子版),2019,11(1):68-71.
|
[9] XIONG Z,LIU YY,HUO SK,et al. Research advances in vitamin K1 in treatment of coagulopathy of liver failure[J]. J Clin Hepatol,2019,35(9):2099-2103.(in Chinese)熊壮,刘扬扬,霍少凯,等.维生素K1治疗肝衰竭凝血功能障碍的研究进展[J].临床肝胆病杂志,2019,35(9):2099-2103.
|
[10] STRAVITZ RT,ELLERBE C,DURKALSKI V,et al. Bleeding complications in acute liver failure[J]. Hepatology,2018,67(5):1931-1942.
|
[11] GOYAL S,JADAUN S,KEDIA S,et al. Thromboelastography parameters in patients with acute on chronic liver failure[J].Ann Hepatol,2018,17(6):1042-1051.
|
[12] ALLISON MG,SHANHOLTZ CB,SACHDEVA A. Hematological issues in liver disease[J]. Crit Care Clin,2016,32(3):385-396.
|
[13] GAZZARD BG,HENDERSON JM,WILLIAMS R. Factor VII levels as a guide to prognosis in fulminant hepatic failure[J]. Gut,1976,17(7):489-491.
|
[14] IZUMI S,LANGLEY PG,WENDON J,et al. Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure[J]. Hepatology,1996,23(6):1507-1511.
|
[15] PEREIRA LM,LANGLEY PG,HAYLLAR KM,et al. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure:Relation to other prognostic indicators[J]. Gut,1992,33(1):98-102.
|
[16] AGARWAL B,WRIGHT G,GATT A,et al. Evaluation of coagulation abnormalities in acute liver failure[J]. J Hepatol,2012,57(4):780-786.
|
[17] HABIB M,ROBERTS LN,PATEL RK,et al. Evidence of rebalanced coagulation in acute liver injury and acute liver failure as measured by thrombin generation[J]. Liver Int,2014,34(5):672-678.
|
[18] FISHER C,PATEL VC,STOY SH,et al. Balanced haemostasis with both hypo-and hyper-coagulable features in critically ill patients with acute-on-chronic-liver failure[J]. J Crit Care,2018,43:54-60.
|
[19] TRIPODI A,PRIMIGNANI M,LEMMA L,et al. Evidence that low protein C contributes to the procoagulant imbalance in cirrhosis[J]. J Hepatol,2013,59(2):265-270.
|
[20] LISMAN T,BERNAL W. Management of hemostatic disorders in patients with advanced liver disease admitted to an intensive care unit[J]. Transfus Med Rev,2017,31(4):245-251.
|
[21] LISMAN T,BAKHTIARI K,ADELMEIJER J,et al. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure[J]. J Thromb Haemost,2012,10(7):1312-1319.
|
[22] PECK-RADOSAVLJEVIC M. Thrombocytopenia in chronic liver disease[J]. Liver Int,2017,37(6):778-793.
|
[23] HUGENHOLTZ GC,ADELMEIJER J,MEIJERS JC,et al. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure:Implications for hemostasis and clinical outcome[J]. Hepatology,2013,58(2):752-761.
|
[24] PONOMAREVA AA,NEVZOROVA TA,MORDAKHANOVA ER,et al. Intracellular origin and ultrastructure of platelet-derived microparticles[J]. J Thromb Haemost,2017,15(8):1655-1667.
|
[25] LEVI M. Pathogenesis and diagnosis of disseminated intravascular coagulation[J]. Int J Lab Hematol,2018,40(Suppl 1):15-20.
|
[26] Thrombosis and Hemostasis Group,Hematology Society of Chinese Medical Association. Consensus of Chinese experts on diagnosis of disseminated intravascular coagulation(version 2017)[J]. Chin J Hematol,2017,38(5):361-363.(in Chinese)中华医学会血液学分会血栓与止血学组.弥散性血管内凝血诊断中国专家共识(2017年版)[J].中华血液学杂志,2017,38(5):361-363.
|
[27] LIU ZG,WANG SY,MAO YL. Progress of laboratory diagnosis of liver disease complicated with DIC[J]. Chin J Health Lab Technol,2012,22(12):3057-3058.(in Chinese)刘志国,王淑英,毛远丽.肝病并发DIC的实验室诊断进展[J].中国卫生检验杂志,2012,22(12):3057-3058.
|
[28] STRAVITZ RT. Potential applications of thromboelastography in patients with acute and chronic liver disease[J]. Gastroenterol Hepatol(N Y),2012,8(8):513-520.
|
[29] LIU HQ,ZENG QB,SONG JC,et al. A comparative study of thromboelastography and Centuryclot coagulation instrument in monitoring the coagulation function of severe patients[J]. Clin J Med Offic,2019,47(4):387-389.(in Chinese)刘慧强,曾庆波,宋景春,等.血栓弹力图与Centuryclot凝血仪监测重症患者凝血功能比较研究[J].临床军医杂志,2019,47(4):387-389.
|
[30] DAVIS J,NORTHUP PG,CALDWELL SH,et al. Viscoelastic testing in liver disease[J]. Ann Hepatol,2018,17(2):205-213.
|
[31] STRAVITZ RT,LISMAN T,LUKETIC VA,et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography[J]. J Hepatol,2012,56(1):129-136.
|
[32] PREMKUMAR M,SAXENA P,RANGEGOWDA D,et al. Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure:An observational cohort study[J]. Liver Int,2019,39(4):694-704.
|